Author

J. Oldenburg

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Pembrolizumab plus lenvatinib with belzutifan or quavonlimab as first-line therapy for advanced renal-cell carcinoma: randomized open-label phase 3 LITESPARK-012 study.

BACKGROUND Pembrolizumab plus lenvatinib is a first-line standard of care for advanced clear-cell renal-cell carcinoma (ccRCC). The phase 3 LITESPARK-012 study (NCT04736706) evaluated efficacy and safety of adding belzutifan (HIF-2α inhibitor) or quavonlimab (anti-CTLA-4) to this regimen. PARTICIPANTS AND METHODS Adu...

B. Rini, T. Choueiri, M. Voss et al. · Annals of Oncology · 0 citations

Open access Oct 2026

A Study on the Measurement of Calcification in Bicuspid Aortic Valves

Abstract Transcatheter aortic valve implantation (TAVI) is widely used in the clinical treatment of severe aortic stenosis. Functionally bicuspid patients are increasingly included in TAVI cohorts. However, their pronounced geometric variability introduces additional challenges for device deployment and procedural outc...

Laura Supp, J. Oldenburg, Matthias Leuchter et al. · Current Directions in Biomed... · 0 citations

Open access Jul 2026

Artificial intelligence in prostate MRI: Comparative diagnostic performance in a high-prevalence cohort

Background Artificial intelligence (AI) is increasingly used in prostate cancer diagnostic workflows but remains insufficiently validated in high-prevalence cohorts often encountered in academic referral centers. Purpose To compare the diagnostic performance of licensed AI software with routine radiologist readings of...

Nádia Gonçalves Ferreira, O. Thomas, K. Gjesdal et al. · Acta Radiologica · 0 citations